AREAS
Areas
COURSE TYPE
CREDITs & duration
profession

Results:

13 Courses

Group 39553
Oncology
Live from IMS 2026: EXCALIBER-RRMM: First Phase 3 CELMoD Data With MRD-Negative CR as a Du...
Group 39553
Oncology
EHA2026: New Data on the Management of Anemia in Myelofibrosis
Group 39553
Oncology
LIVE from ASCO26: New Data on CelMOD Therapy for Multiple Myeloma
Group 39553
Oncology
ASH2025 Update on Management of Anemia in Patients with Myelofibrosis
Group 39553
Oncology
Update on Management of Anaemia in Patients with Myelofibrosis
np microphone 888718 0E193A 1
Oncology
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to ...
np document 888746 0E193A 5
Oncology
CAR T Research and Treatment Advances in Chronic Lymphocytic Leukemia (CLL), Mantle Cell L...
np document 888746 0E193A 5
Oncology
The Advancing Role of PARP Inhibitor Combination Therapies to Improve Outcomes for Patient...
np document 888746 0E193A 5
Oncology
Utilizing Immunohistochemistry Testing, Biomarkers, and Targeted Therapeutics to Optimize ...
np document 888746 0E193A 5
Oncology
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to ...
np document 888746 0E193A 5
Oncology
Advances in Biomarkers and Anti BCMA Therapeutics to Improve Outcomes in Patients with Rel...
np document 888746 0E193A 5
Gastroenterology
Oncology
Therapeutic Advances in the Management of Patients with Gastrointestinal Cancer